CAZZANIGA MARINA ELENA

Ruolo:

Ricercatore a tempo determinato

Settore scientifico disciplinare:

ONCOLOGIA MEDICA (MED/06)

Afferenza:

E-mail:

Caruso, A., Caccuri, F., Bugatti, A., Zani, A., Vanoni, M., Bonfanti, P., et al. (2021). Methotrexate inhibits SARS-CoV-2 virus replication "in vitro". JOURNAL OF MEDICAL VIROLOGY, 93(3), 1780-1785. Dettaglio
Bani, M., Rossi, E., Cortinovis, D., Russo, S., Gallina, F., Hillen, M., et al. (2021). Validation of the Italian version of the full and abbreviated Trust in Oncologist Scale. EUROPEAN JOURNAL OF CANCER CARE, 30(1) [10.1111/ecc.13334]. Dettaglio
Zeppellini, A., Galimberti, S., Leone, B., Pacifico, C., Riva, F., Cicchiello, F., et al. (2021). Comparison of tumor microenvironment in primary and paired metastatic ER+/HER2- breast cancers: results of a pilot study. BMC CANCER, 21(1), 260-270 [10.1186/s12885-021-07960-z]. Dettaglio
Capici, S., Sala, L., Galimberti, S., Valsecchi, M., Squillace, N., Gustinetti, G., et al. (2021). The role for tocilizumab in covid-19 patients: Reflections on monza cohort data. INFECTION AND DRUG RESISTANCE, 14, 1389-1392. Dettaglio
Jacobs, S., Robidoux, A., Abraham, J., Pérez-Garcia, J., La Verde, N., Orcutt, J., et al. (2020). Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer. BREAST CANCER RESEARCH, 22(1). Dettaglio

Futuri studenti - Iscrizioni